Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
Pedro Henrique Las Casas, Professor at Sorbonne University, Professor of Internal Medicine at Federal University of Minas Gerais (UFMG), Hematologist at Grupo Oncoclínicas, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cancers, adding:
“Happy to share our latest publication in Cancers with Grigoris Gerotziafas.
‘Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin‘
In this study, we explored how anticoagulant agents and quercetin influence cancer cell procoagulant activity, thrombin generation, and endothelial dysfunction induced by cancer-derived extracellular vesicles.
Our findings provide new insights into the complex interactions between cancer, thrombosis, and the vascular microenvironment.
I am grateful to my colleagues and collaborators for their valuable contributions, and especially proud to be part of the Cancer–Angiogenesis–Thrombosis and Hemostasis (CaVITE) research team at the CRSA PARIS, Inserm Paris UMR_S_938, Sorbonne Université.
Many thanks to all co-authors and collaborators who made this work possible.”
Title: Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin
Authors: Mohammed A. Baghdadi, Pedro Henrique Fernandes do Carmo Las Casas, Elisabeth Mbemba, Aurélie Rousseau, Prakasha Kempaiah, Andrey A. Svistunov, Victoria Bitsadze, Michèle Sabbah, Jawed Fareed, Patrick Van Dreden, Varvara Trachana, Eleftheria Lefkou, Grigoris Gerotziafas
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism
-
Sep 4, 2026, 21:54Gianluca Costamagna: Investigating the Link Between Cancer and Acute Ischemic Stroke
-
Sep 4, 2026, 21:50Ben Creagh-Brown: PRAGUE-26 and HI-PEITHO Similar Benefits With Important Differences
-
Sep 4, 2026, 21:48Jin-Xiong She: Homocysteine beyond Heart Disease – The Methylation-Mobility Connection
-
Sep 4, 2026, 21:44Aravind Palraj: Anemia of Chronic Inflammation is Not Just “Iron Deficiency”
-
Sep 4, 2026, 21:41Chokri Ben Lamine: Fundamental HSCT Workshop for Hematology Fellows at HAAG 2026
-
Sep 4, 2026, 21:39Pierre Sabouret: A Good Surprise Our New Publication in Life Is Online